Guangxi Medical University
Clinical trials sponsored by Guangxi Medical University, explained in plain language.
-
Can a targeted liver treatment stop cancer from coming back after surgery?
Disease control Recruiting nowThis study is for people with liver cancer who have had surgery to remove the tumor but are at high risk of the cancer returning. It tests whether adding a procedure called TACE (which delivers chemotherapy directly to the liver) after surgery can help keep the cancer away longer…
Phase: PHASE3 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated May 26, 2026 11:59 UTC
-
New surgery may help stomach cancer patients eat again
Symptom relief Recruiting nowThis study compares a new type of stomach bypass surgery (partial stomach-partitioning gastrojejunostomy) to the standard surgery for people with advanced stomach cancer that blocks food from leaving the stomach. The goal is to see which surgery better relieves the blockage, redu…
Phase: NA • Sponsor: Guangxi Medical University • Aim: Symptom relief
Last updated May 26, 2026 12:01 UTC
-
2000 liver cancer patients help reveal best Pre-Surgery treatments
Knowledge-focused Recruiting nowThis study looks back at the medical records of 2000 people with liver cancer in Guangxi, China, who received treatments like chemotherapy, targeted therapy, or immunotherapy before surgery. The goal is to figure out which treatments work best and which patients benefit the most.…
Sponsor: Guangxi Medical University • Aim: Knowledge-focused
Last updated May 26, 2026 12:04 UTC